» Articles » PMID: 29076883

Intimate Partner Violence and Self-Reported Pre-exposure Prophylaxis Interruptions Among HIV-Negative Partners in HIV Serodiscordant Couples in Kenya and Uganda

Overview
Date 2017 Oct 28
PMID 29076883
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Oral pre-exposure prophylaxis (PrEP) is effective for HIV prevention, and PrEP delivery studies are investigating ways to deliver PrEP with high adherence. However, in many settings with high HIV burden, intimate partner violence (IPV) is reported often and could be a barrier to the effective PrEP use. We examined the association between IPV and interruptions in PrEP use.

Methods: We analyzed data from 1013 serodiscordant heterosexual couples enrolled in a large PrEP demonstration project in Kenya and Uganda, the Partners Demonstration Project. At quarterly study visits, HIV-negative participants receiving PrEP were asked about interruptions in their PrEP use and experiences with IPV. The association between IPV and PrEP interruptions was analyzed using multivariable generalized estimating equations.

Results: At baseline and follow-up, there were 53 visits with reports of abuse by 49 HIV-negative partners, including physical, economic, and verbal IPV. Interruptions in PrEP use were reported at 328 visits (7.1% of all visits) by 249 people. The median length of PrEP interruption was 28 days (interquartile range: 7-45). The frequency of PrEP interruptions among those reporting IPV was 23.8% and those without IPV was 6.9%. PrEP interruption was significantly associated with IPV after adjustment for age and frequency of sexual intercourse (adjusted odds ratio = 2.6, 95% confidence interval: 1.2 to 6.0).

Conclusions: IPV was more likely to be reported at visits when PrEP interruptions were also reported, which may have implications for sustained adherence to PrEP. Within PrEP delivery programs, there may be opportunities to assess individual safety and well-being to bolster adherence.

Citing Articles

Alignment of PrEP Use With Potential HIV Exposure in Young Women and Men in Uganda.

Wu L, Ssebuliba T, Muwonge T, Bambia F, Stein G, Nampewo O J Acquir Immune Defic Syndr. 2024; 98(4):326-333.

PMID: 39630076 PMC: 11841727. DOI: 10.1097/QAI.0000000000003573.


Integrating a mental health intervention into PrEP services for South African young women: a human-centred implementation research approach to intervention development.

Velloza J, Ndimande-Khoza N, Mills L, Concepcion T, Gumede S, Chauke H J Int AIDS Soc. 2024; 27 Suppl 1:e26274.

PMID: 38965973 PMC: 11224591. DOI: 10.1002/jia2.26274.


The impact of intimate partner violence on PrEP adherence among U.S. Cisgender women at risk for HIV.

Anderson K, Blumenthal J, Jain S, Sun X, Amico K, Landovitz R BMC Public Health. 2024; 24(1):1461.

PMID: 38822300 PMC: 11140862. DOI: 10.1186/s12889-024-18946-4.


Exploring adolescent girls and young women's PrEP-user profiles: qualitative insights into differentiated PrEP delivery platform selection and engagement in Cape Town, South Africa.

Rousseau E, Sikkema K, Julies R, Mazer K, OMalley G, Heffron R J Int AIDS Soc. 2024; 27(5):e26254.

PMID: 38695101 PMC: 11063778. DOI: 10.1002/jia2.26254.


How men influence young women taking PrEP: perspectives from young women, male partners, and male peers in Siaya county, Western Kenya.

Agot K, Onyango J, Perry B, Molokwu N, Taylor J, Ngoje D BMC Womens Health. 2024; 24(1):218.

PMID: 38570779 PMC: 10993511. DOI: 10.1186/s12905-024-03044-9.


References
1.
Ilika A . Women's perception of partner violence in a rural Igbo community. Afr J Reprod Health. 2006; 9(3):77-88. View

2.
Were E, Curran K, Delany-Moretlwe S, Nakku-Joloba E, Mugo N, Kiarie J . A prospective study of frequency and correlates of intimate partner violence among African heterosexual HIV serodiscordant couples. AIDS. 2011; 25(16):2009-18. PMC: 3718250. DOI: 10.1097/QAD.0b013e32834b005d. View

3.
Kalichman S, Simbayi L, Cloete A, Mthembu P, Mkhonta R, Ginindza T . Measuring AIDS stigmas in people living with HIV/AIDS: the Internalized AIDS-Related Stigma Scale. AIDS Care. 2008; 21(1):87-93. DOI: 10.1080/09540120802032627. View

4.
Cottrell M, Yang K, Prince H, Sykes C, White N, Malone S . A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without Emtricitabine. J Infect Dis. 2016; 214(1):55-64. PMC: 4907409. DOI: 10.1093/infdis/jiw077. View

5.
McCormack S, Dunn D, Desai M, Dolling D, Gafos M, Gilson R . Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2015; 387(10013):53-60. PMC: 4700047. DOI: 10.1016/S0140-6736(15)00056-2. View